Erratum to: Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy
© The Author(s) 2016
Published: 1 November 2016
The original article was published in Journal of Translational Medicine 2016 14:109
Erratum to: J Transl Med (2016) 14:109 DOI 10.1186/s12967-016-0849-1
Unfortunately, the original version of this article  contained an error. The affiliations were incorrect. The correct author list and associated affiliations can be found in this erratum.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Zhang L, Ding Wy, Wang Zh, Tang Mx, Wang F, Li Y, Zhong M, Zhang Y, Zhang W. Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy. J Transl Med. 2016;14:109. doi:10.1186/s12967-016-0849-1.View ArticlePubMedPubMed CentralGoogle Scholar